Gurpreet Singh
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- Kelly K. Hunt (2 shared papers)Henry M. Kuerer (2 shared papers)S. Eva Singletary (2 shared papers)Merrick I. Ross (2 shared papers)Lisa A. Newman (2 shared papers)Richard L. Theriault (1 shared paper)Aman U. Buzdar (1 shared paper)Terry L. Smith (1 shared paper)
- Journals
- The Breast Journal (8 papers)Applied immunohistochemistry & molecular morphology (6 papers)Nuclear Medicine Communications (4 papers)Journal of Surgical Oncology (3 papers)Cancer Biotherapy and Radiopharmaceuticals (3 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Gurpreet Singh
131 papers receiving 2.8k citations
Gurpreet Singh's Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 966
- Applied Microbiology and Biotechnology 84
- Oncology 684
- Pathology and Forensic Medicine 367
- Anesthesiology and Pain Medicine 89
Countries citing papers authored by Gurpreet Singh
This map shows the geographic impact of Gurpreet Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gurpreet Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gurpreet Singh more than expected).
Fields of papers citing papers by Gurpreet Singh
This network shows the impact of papers produced by Gurpreet Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gurpreet Singh. The network helps show where Gurpreet Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside Gurpreet Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy Hit paper breakdown → | 1999 | 1069 |
| 2 | 2016 | 192 | |
| 3 | 2007 | 108 | |
| 4 | 2020 | 78 | |
| 5 | 2016 | 61 | |
| 6 | 2014 | 45 | |
| 7 | 2013 | 41 | |
| 8 | 2012 | 40 | |
| 9 | 2011 | 36 | |
| 10 | 2006 | 34 | |
| 11 | 2005 | 31 | |
| 12 | 2019 | 31 | |
| 13 | 2016 | 31 | |
| 14 | 2013 | 31 | |
| 15 | 2014 | 31 | |
| 16 | 2012 | 30 | |
| 17 | 2013 | 29 | |
| 18 | 2012 | 29 | |
| 19 | 2020 | 27 | |
| 20 | 1999 | 27 |
About Gurpreet Singh
Gurpreet Singh is a scholar working on Oncology, Surgery, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 138 papers that have together received 2.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (11 papers), HER2/EGFR in Cancer Research (10 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Cancer and Skin Lesions (8 papers), Cancer Cells and Metastasis (6 papers), Cancer Diagnosis and Treatment (6 papers) and Anesthesia and Pain Management (6 papers). The work is most often cited by research in Cancer Research (966 citations), Applied Microbiology and Biotechnology (84 citations), Oncology (684 citations), Pathology and Forensic Medicine (367 citations) and Anesthesiology and Pain Medicine (89 citations). Gurpreet Singh has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Kelly K. Hunt, Henry M. Kuerer, S. Eva Singletary, Merrick I. Ross, Lisa A. Newman, Richard L. Theriault, Aman U. Buzdar, Terry L. Smith, Fred C. Ames and Kapil Dhingra. Their work appears in journals such as The Breast Journal, Applied immunohistochemistry & molecular morphology, Nuclear Medicine Communications, Journal of Surgical Oncology and Cancer Biotherapy and Radiopharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.